Randox Microalbumin

FDA 510(k) K002674 · Randox Laboratories, Ltd.

Substantially Equivalent

510(k) numberK002674

Submission

Device name
Randox Microalbumin
Applicant
Randox Laboratories, Ltd.
Crumlin, Co. Antrim, IE
Received
August 28, 2000
Decision date
October 5, 2000
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
DDZ – Albumin, Fitc, Antigen, Antiserum, Control
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5040
Specialty
Immunology

Other 510(k)s with product code DDZ

510(k)DeviceApplicantDecision
K050576Microalbumin Tia Reagent; Malb Calibrator Set 200; Malb Control-L, Control-HDDZ · Traditional Good Biotech Corp.04/21/2005SE
K023860Microalbumin Reagent Set and CalibratorsDDZ · Traditional Pointe Scientific, Inc.,04/28/2003SE
K831902Fluorescein Conjugated Immunoglobin-DDZ · Traditional Dako Corp.07/18/1983SE

More from Dako Corp.

510(k)DeviceDecision
K250741Evidence MultiSTAT DOA Urine MultiPlexDJG · Traditional 01/23/2026SE
K221550Evidence MultiSTAT DOA Urine MultiPlexDJG · Traditional 10/05/2023SE
K220451Evidence MultiSTAT DOA Urine MultiPlex, Evidence MultiSTATDJG · Traditional 10/05/2023SE
K230890ISE ElectrodesCEM · Special 09/08/2023SE
K182042Randox Calcium (Ca)CJY · Traditional 10/23/2018SE
K162200Randox RX Daytona Plus Magnesium (MG)JGJ · Traditional 04/28/2017SE
K162275Randox RX Daytona Plus Alkaline Phosphatase (ALP)CJE · Traditional 04/21/2017SE
K161691Direct LDL Cholesterol (LDL)MRR · Traditional 03/20/2017SE
K152085Liquid CO2-2 (LCO2-2)KHS · Traditional 02/24/2016SE
K152343Direct BilirubinJFM · Traditional 02/16/2016SE

Questions and answers

When was Randox Microalbumin cleared by the FDA?

Randox Microalbumin (K002674) received a 510(k) decision of Substantially Equivalent on October 5, 2000, 38 days after the submission was received.

What is the product code of K002674?

The FDA product code is DDZ – Albumin, Fitc, Antigen, Antiserum, Control, a Class II (moderate risk) device regulated under 21 CFR 866.5040.